Go to main content
Contact us
19 JAN 2016, 08:00
PRESS RELEASE
REGULATORY

Täby, 19 January, 2016 - Mycronic AB (publ), has received an order for a mask writer from the Prexision series for display applications from a customer in Asia. The system is scheduled to be delivered during the first half of 2017.

Mycronic offers mask writers for the manufacturing of photomasks within different fields of application. These areas are display manufacturing (for TV, smart phones and tablets among other things) and applications within the multi-purpose market, a broad segment comprising many different application areas.

”The customer has placed an order for a Prexsion-8 mask writer, with functionality equal to manu-facturing of Generation 6 photomasks. The customer has the possibility to upgrade the system later to a full scale P-8,” says Magnus Råberg, Senior VP & General Manager for business area PG at Mycronic AB. “With this system, the customer increases the possibilities for advanced LCD photomask manufacturing, to be used in display applications,” Magnus Råberg concludes.

The price level for a Prexision-8 mask writer is normally in the span USD 25-30 million depending on configuration and customization. This price for this machine in its current configuration is in the span USD 20-25 million.

Contacts at Mycronic:
Magnus Råberg                                                                
Sr VP & General Manager PG                                            
Tel: +46 8 638 52 00
magnus.raberg@mycronic.com
 
 

Per Ekstedt
CFO
Tel: +46 8 638 52 00
per.ekstedt@mycronic.com

 

About Mycronic AB
Mycronic AB is a Swedish high-tech company engaged in developing, manufacturing and marketing of production equipment for the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, Singapore, South Korea, the Netherlands, United Kingdom and the United States. For more information see our web site at:
www.mycronic.com 

Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR.

The information is of the type that Mycronic is required to disclose under the Financial Instruments trading Act and/or the Swedish Securities Markets Act. The information was submitted for publication on 19 January, 2016.